Skip to Main Content

Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects

Conditions

Mental Health & Behavioral Research

Phase III

What is the purpose of this trial?

The aim of the study is to provide insight into the impact of the immunosuppressant drug sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant medication, ketamine.

  • Trial with
    Pfeiffer Research Foundation
  • Start Date
    05/31/2016
  • End Date
    12/30/2016
Trial Image

For more information about this study, contact:

Selin O. Goktas

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    04/05/2019
  • Study HIC
    #1504015604